However, AAT is functionally inactivated, when interacting with proteases or reactive oxygen species27,29,30, which may eventually result in acquired functional AAT deficiency in patients undergoing ECMO. This evidence concerns the gene SERPINA1 and hyperinsulinemic hypoglycemia, familial, 4.